Page last updated: 2024-09-03

dx 9065 and ym 60828

dx 9065 has been researched along with ym 60828 in 3 studies

Compound Research Comparison

Studies
(dx 9065)
Trials
(dx 9065)
Recent Studies (post-2010)
(dx 9065)
Studies
(ym 60828)
Trials
(ym 60828)
Recent Studies (post-2010) (ym 60828)
17002702

Protein Interaction Comparison

ProteinTaxonomydx 9065 (IC50)ym 60828 (IC50)
Coagulation factor X Mus musculus (house mouse)0.006
ProthrombinHomo sapiens (human)0.0077
Coagulation factor XHomo sapiens (human)0.002
Anionic trypsin-2Rattus norvegicus (Norway rat)0.063

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1
Brady, L; Jones, SD; Liebeschuetz, JW; Mahler, J; Martin, H; Morgan, PJ; Murray, CW; Rimmer, AD; Roscoe, JM; Waszkowycz, B; Welsh, PM; Wilkinson, K; Wylie, WA; Young, SC1
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR1

Reviews

2 review(s) available for dx 9065 and ym 60828

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000
Factor Xa inhibitors: next-generation antithrombotic agents.
    Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

    Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010

Other Studies

1 other study(ies) available for dx 9065 and ym 60828

ArticleYear
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
    Journal of medicinal chemistry, 2002, Mar-14, Volume: 45, Issue:6

    Topics: Animals; Benzamidines; Combinatorial Chemistry Techniques; Drug Design; Enzyme Inhibitors; Factor Xa Inhibitors; Humans; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship

2002